The Goat Polyclonal anti-APOC3 antibody is suitable to detect APOC3 in samples from Human. It has been validated for WB, IP, IHC (p), IHC (fro) and EIA.
This product has been prepared by Immunoaffinity chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities. Typically less than 1 % cross reactivity against other types of ApoLipoprotein was detected by ELISA against purified standards. This antibody recognizes Human ApoLipoprotein C-III and has negligible cross-reactivity with Type A-I, A-II, B, C-I, C-II, E and J ApoLipoproteins. Non-specific cross reaction of anti-ApoLipoprotein antibodies with other Human serum proteins is negligible.
Purification
Immunoaffinity Chromatography.
Immunogen
Synthetic full-length Apolipoprotein Type C-III (not selected epitopes) using conventional peptide technology.
This Apolipoprotein antibody has been used for indirect trapping ELISA for quantitation ofantigen in serum using a standard curve, for Immunoprecipitation, Western blotting forhighly sensitive qualitative analysis and for Immunohistochemistry. Recommended Dilutions: ELISA: 1/5,000-1/10,000. Western blot: 1/5,000-1/10,000. Immunoprecipitation: 1/100. Immunohistochemistry Paraffin Sections: 2.5 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
1.0 mg/mL (by UV absorbance at 280 nm)
Buffer
0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0, with 0.01 % Sodium Azide as preservative.
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freezing and thawing. Dilute only prior to immediate use.
Storage
-20 °C
Storage Comment
Store the antibody undiluted (in aliquots) at -20 °C.
Target
APOC3
(Apolipoprotein C-III (APOC3))
Alternative Name
Apolipoprotein C III (Apo CIII)
Background
At least 9 distinct polymorphic forms of apolipoproteins are known. The apolipoproteins act as stabilizers of the intact lipoprotein particles. Quantitative measurements of HDL, LDL and VLDL particles in human serum are often used to estimate an individuals' relative risk of coronary heart disease. In addition, quantitative immunological measurements of certain apolipoproteins (especially A1 and B) have been suggested to be more accurate estimators of coronary heart disease than measurements of lipoprotein particles (especially HDL and LDL). Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. It inhibits lipoprotein lipase and hepatic lipase and it is thought to delay catabolism of triglyceride-rich particles. An increase in ap °C-III levels induces the development of hypertriglyceridemia.Synonyms: Apo-CIII, Ap °C-III, Ap °C3, Apolipoprotein C-III, Apolipoprotein C3